PRESS RELEASES

Coulter Partners places Non-executive Director at Australian life sciences company, QBiotics Group Ltd

Coulter Partners successfully completed a search assignment for QBiotics and is pleased to announce the placement of Sergio Duchini as Non-executive Director.

QBiotics is an unlisted public Australian life sciences company that specializes in the discovery and development of novel small molecules to treat complex medical conditions. Its current therapeutic focus is on oncology and wound healing. The Company also has an early-stage antibiotics program.

Sergio Duchini is a seasoned executive with over 30 years of experience across biotechnology, healthcare, and technology. He chairs Neurizon Therapeutics and is a Non-executive Director for Enlitic Inc. Previously, he held leadership roles at Lymphoma Australia, AusBiotech, and was a Deloitte Tax Partner for 23 years, advising on innovation and M&A. Sergio is recognized for strategic leadership and governance expertise.

Commenting on his appointment, Mr. Duchini said: “I’m delighted to be joining the Board of QBiotics at this important stage in its history. I have long admired QBiotics’ pioneering science and have been impressed by the strength of its innovation platform, translational capability, and commitment to delivering real-world impact. I look forward to contributing to QBiotics’ continued growth and global aspirations.”

QBiotics’ Chair, Mark Fladrich said of the appointment, “On behalf of my fellow directors, we are delighted to welcome Sergio to the Board of QBiotics. His deep experience across biotechnology, healthcare and professional services, combined with his proven governance and strategic insights will be invaluable in supporting our clinical and commercial progress.”

Mr. Fladrich added: “We’re grateful to Coulter Partners for their ongoing support and expertise. Their consistent success in identifying top-tier talent in the Asia-Pacific region is unparalleled. Having already placed our CEO and several Non-executive Directors, including myself, they have a strong understanding of our needs and have played a key role in helping build the right skillset across our leadership team.”